TABLE 1.
Clinicopathological features of PANDEMIC‐group
| # | Sex | Age | Date of surgery | Disease group | Pathology | Stage | Type of surgery | SARS‐Cov‐2 test | HT (d) | FU (d) | Complications |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | F | 87 | 24th of Feb | Malignant | Nasal BSC | yr pT1N0M0 | Rhinectomy revision + ER | n.p. | 6 | 71 | … |
| 2 | M | 89 | 25th of Feb | Epistaxis | Left epistaxis | … | Cauterization | n.p. | 5 | 70 | … |
| 3 | F | 82 | 26th of Feb | Inflammatory | Invasive mycosis | … | FESS | n.p. | 5 | 69 | … |
| 4 | M | 50 | 28th of Feb | Benign | Inverted papilloma | … | ER | n.p. | 3 | 67 | … |
| 5 | M | 53 | 2nd of Mar | Malignant | Nasopharyngeal ACC | yr pT4bN0M0 | NER III | n.p. | 10 | 64 | … |
| 6 | M | 63 | 2nd of Mar | Malignant |
Sphenoidal mts from prostatic ADC |
… | Endoscopic endonasal biopsy | n.p. | 4 | 64 | … |
| 7 | M | 51 | 3rd of Mar | Benign | Inverted papilloma | … | ER (PLA) | n.p. | 3 | 63 | … |
| 8 | M | 73 | 3rd of Mar | Benign | Inverted papilloma | … | ER | n.p. | 6 | 63 | … |
| 9 | F | 13 | 4th of Mar | Benign | Frontal‐orbital dysplasia | … | ER | n.p. | 4 | 62 | … |
| 10 | M | 62 | 5th of Mar | Benign | Intraconal hemangioma | … | ER | n.p. | 7 | 61 | … |
| 11 | M | 12 | 5th of Mar | Inflammatory | Orbital abscess | … | Drainage (superior eyelid approach) | n.p. | 6 | 61 | … |
| 12 | M | 65 | 6th of Mar | Malignant | Maxillary SCC | pT3N0M0 | Endoscopic assisted radical maxillectomy | n.p. | 32 | 60 | … |
| 13 | F | 59 | 9th of Mar | Functional | Severe bilateral Graves ophthalmopathy | … | Orbital decompression (combined superior eyelid‐transnasal approach) | n.p. | 10 | 57 | … |
| 14 | F | 49 | 11th of Mar | Malignant | Chondrosarcoma | pT4bN0M0 | Endoscopic endonasal debulking | n.p. | 3 | 55 | Brain abscess |
| 15 | M | 70 | 13th of Mar | Malignant | Sinonasal ITAC | pT2N0M0 | ERTC | n.p. | 9 | 53 | … |
| 16 | M | 75 | 19th of Mar | Malignant | Maxillary ACC relapse | yr pT3N2aM0 | Radical maxillectomy + mRND | n.p. | 31 | 47 | … |
| 17 | F | 46 | 25th of Mar | CSFL | Left olfactory cleft meningocele | … | Skull base reconstruction | − | 9 | 41 | … |
| 18 | M | 36 | 2nd of Apr | Malignant | Sinonasal SCC in IP | pT2N0M0 | ER | + | 24 | 33 | … |
| 19 | F | 83 | 6th of Apr | Epistaxis | Left epistaxis | … | Cauterization | − | 6 | 29 | … |
| 20 | M | 63 | 6th of Apr | Malignant | Sinonasal hemangiopericytoma | pT4aN0M0 | ER | − | 6 | 29 | … |
| 21 | M | 71 | Apr‐9 | Malignant | Left maxillary SCC | pT3N0M0 | Endoscopic assisted radical maxillectomy | − | 18 | 26 | … |
| 22 | F | 80 | Apr‐14 | Malignant | Sinonasal NEC | yr pT4aN3bM0 | ER, OE, mRND | − | 18 | 21 | … |
| 23 | F | 47 | Apr‐15 | Inflammatory | Frontal sinus prosthesis superinfection | … | Drainage (frontal osteoplasty approach) | − | 11 | 20 | … |
| 24 | M | 39 | Apr‐21 | CSFL | Right olfactory cleft CSFL | … | Skull base reconstruction | − | 10 | 14 | … |
Abbreviations: ACC, adenoid cystic carcinoma; ADC, adenocarcinoma; BSC, basal cell carcinoma; CSFL, cerebrospinal fluid leak; ER, endoscopic resection; ERTC, endoscopic resection with transnasal craniectomy; FESS, functional endoscopic surgery; FU, follow‐up; HT, hospitalization time; IP, inverted papilloma; ITAC, intestinal‐type adenocarcinoma; mRND, modified radical neck dissection (levels I‐V); NEC, neuroendocrine carcinoma; n.p., not performed; OE, orbital exenteration; PLA, prelacrimal approach; SCC, squamous cell carcinoma; +, testing positive; ‐, testing negative.